Finance

Lists
A1SN34:BVMF
Ascendis Pharma A/S Bdr
76,48 BRL
0,00%
(0,00) 1D
5-окт., 16:02:32 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1SN34...
Mkt. cap
15,07 млд
Avg. vol.
72,00
Volume
0,00
52-wk high
94,05 BRL
52-wk low
70,00 BRL
Shares outstanding
62,38 млн
No. of employees
1 миң
Mkt. cap
15,07 млд
Avg. vol.
72,00
Volume
0,00
52-wk high
94,05 BRL
52-wk low
70,00 BRL
Shares outstanding
62,38 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Ascendis Pharma A/S Bdr
CEO-
Employees1,19 миң
Founded2006
Headquarters-
Sector-
Last report
2026-ж., 13-авг.
Fiscal period
Q2 2026
0,90 € / 0,77 €
+17,39%beat
Revenue / Est. (EUR)
339,28 млн / 329,90 млн
+2,84%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
213,63 млн
247,50 млн
246,60 млн
339,28 млн
Cost of goods sold
22,35 млн
23,60 млн
17,52 млн
27,66 млн
Cost of revenue
22,35 млн
23,60 млн
17,52 млн
27,66 млн
Research and development expenses
66,88 млн
82,20 млн
59,04 млн
75,89 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
113,40 млн
139,31 млн
145,23 млн
173,34 млн
Operating expense
180,28 млн
221,51 млн
204,27 млн
91,16 млн
Total operating expenses
202,64 млн
245,11 млн
221,79 млн
118,82 млн
Operating income
11,00 млн
2,39 млн
24,81 млн
220,46 млн
Other non operating income
-
-105,57 млн
-
-
EBT including unusual items
-57,37 млн
-26,70 млн
-48,18 млн
230,09 млн
EBT excluding unusual items
-57,37 млн
-34,21 млн
-48,18 млн
230,09 млн
Income tax expense
3,62 млн
6,86 млн
-677,52 млн
23,12 млн
Effective tax rate
-6,30%
-25,68%
1 406,31%
10,05%
Other operating expenses
-
-
-
-158,07 млн
Net income
-60,99 млн
-33,56 млн
629,34 млн
206,97 млн
Net profit margin
-28,55%
-13,56%
255,21%
61,00%
Earnings per share
-1,00
-0,55
0,27
0,90
Interest and investment income
6,04 млн
64,06 млн
4,52 млн
19,96 млн
Interest expense
-66,90 млн
-74,65 млн
-67,26 млн
-14,17 млн
Net interest expenses
-60,87 млн
-10,59 млн
-62,74 млн
5,79 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
15,02 млн
3,60 млн
29,03 млн
225,03 млн
Gain or loss from assets sale
-
-
-
21,00 миң
AI content may include mistakes. Learn more
Google колдонмолору